← Back to home

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS (ECOG PS) SCORE OF 0 TO 2

Clinical trials for EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS (ECOG PS) SCORE OF 0 TO 2 explained in plain language.

Never miss a new study

Get alerted when new EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS (ECOG PS) SCORE OF 0 TO 2 trials appear

Sign up with your email to follow new studies for EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS (ECOG PS) SCORE OF 0 TO 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Single-Drug immunotherapy shows promise for advanced lung cancer

Disease control Recruiting now

This study looks at how well the immunotherapy drug ivonescimab works when used alone as the first treatment for people with advanced non-small cell lung cancer that has a specific marker (PD-L1 positive) and no targetable gene mutations. About 265 participants will receive ivone…

Matched conditions: EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS (ECOG PS) SCORE OF 0 TO 2

Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control

Last updated Jul 12, 2026 00:00 UTC

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS (ECOG PS) SCORE OF 0 TO 2

Get alerted when new EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS (ECOG PS) SCORE OF 0 TO 2 trials appear

Single-Drug immunotherapy shows promise for advanced lung cancer